|
|
![See the potential in every drop]()
|
|
DISCOVER THE LATEST EVIDENCE, EXPAND YOUR
EXPERTISE AND MEET US AT CIRSE 2026
|
|
![Prepare for your visit to CIRSE]()
|
![]()
|
|
MASTER VASCULAR EMBOLIZATION
• Reduced recurrence rate 3,4,5,6,7,9
• Decreased procedural times 1,2,8
• Minimized radiation exposure 1,3,8
|
|
![]()
|
|
Expand your embolization options with a complete
portfolio designed to support a wide range of
clinical procedures.
Meet us at booth D12
|
|
|
![]()
|
FROM EVIDENCE TO PRACTICE
Our scientific program is designed to support your learning
and the adoption of embolization in daily practice
|
|
![]()
|
Sunday, September 6th
12:30 - 13:30 (CET)
Auditorium 11
|
|
Vascular Embolization Practice: Real-World
Insights with Lipiodol® & Glubran® 2 Radiology
|
|
![]()
|
MODERATOR 1
Prof. Tiago Bilhim
|
![]()
|
MODERATOR 2
Prof. Romaric Loffroy
|
|
|
12:30 - 12:45
• Trauma & Hemorrhage Control: Lessons from Embolization Practice
Dr. Francesco Giurazza
|
|
12:45 - 13:00
• Optimize your Prostate Artery Embolization technique
Dr. Federico Collettini
|
|
13:00 - 13:15
• Varicocele Embolization: practical experience and long term consideration
Dr. Karim Abd El Tawab
|
|
13:15 - 13:30
• Reduce recurrences in Bronchial Artery Embolization
Prof. Gianpolo Carrafiello
|
|
|
|
|
![]()
|
![]()
|
|
11:00 - 11:30am CET
Role of embolic agents in
Liver deprivation
|
|
![]()
|
|
2:00 - 2:30pm CET
The science behind Lipiodol® and
Glubran® 2 Radiology
|
|
3:45 - 4:15pm CET
Safely and Effectively controlling
Haemorrage with Glue
|
|
|
![]()
|
|
9:30 - 10:00am CET
12:30 - 1:00pm CET
Glubran® 2 Radiology & Lipiodol®: Tips
and Tricks and Complication handling
|
|
11:15 – 11:45am CET
Current Experience with Glubran® 2
Radiology in PAE: Expert Perspectives
|
|
![]()
|
|
11:00 - 11:30pm CET
The science behind Lipiodol® and
Glubran® 2 Radiology
|
|
12:30 - 1:00pm CET
Get confident with Glubran® 2
Radiology
|
|
|
|
![]()
|
|
|
![]()
|
STANDARDIZE YOUR PRACTICE
Prepare your embolic mixture with Qitexio® using
a standardized workflow and train our on our
flow model
|
|
![]()
|
SEE THROUGH THE OPERATOR’S EYES
Experience procedures through our immersive
VR cath lab
|
|
|
|
|
EXPLORE THE ART OF INTERVENTIONAL
Discover clinical images, videos and the original
Lipiodol® packaging.
|
|
|
We look forward to connecting with you in Copenhagen!
The Guerbet Team
|
|
|
|
|
|
|
This information is intended for an international audience or is provided during an international event. Lipiodol® Ultra Fluid (Ethyl esters of iodized fatty acids of poppy seed
oil) is not registered in all countries.Be aware that Indications, posology, and presentations may differ from country to country.For current and complete prescribing information
refer to the local Summary of Product Characteristics (SmPC) and /or contact your local Guerbet organization.
|
|
|
|
|
For Healthcare Professionals only.
Glubran® 2 Radiology is a Class III Medical Device according to Rule 8, Annex VIII of Regulation (EU) 2017/745 and bears the CE Mark 0373 issued by Istituto Superiore di
Sanità Italiano.
Before use, please carefully read the Instructions for Use (IFU), Rev. 15 dated 03/06/2024, which contain complete information regarding indications, contraindications,
warnings, precautions, instructions for use, and potential adverse events.
Manufacturer: GEM Srl.
Product availability and approved indications may vary according to local regulatory approvals and country-specific requirements.
|
|
|
*Distribution countries : France, Germany, Austria, Poland, Belgium, The Netherlands, Sweden, Denmark, Finland, South Africa
1. Salet, E., Crombé, A., Grenier, N., Marcelin, C., Lebras, Y., Jambon, E., Coussy, A., Cornelis, F. H., & Petitpierre, F. (2022). Prostatic zObstruction: Single-Centre Retrospective
Study Comparing Microspheres versus N-Butyl cyanoacrylate. CardioVascular and Interventional Radiology, 45(6), 814–823. https://doi.org/10.1007/s00270-022-03069-3
2. Chevallier, O., Comby, P., Guillen, K., Pellegrinelli, J., Mouillot, T., Falvo, N., Bardou, M., Midulla, M., Aho-Glélé, S., & Loffroy, R. (2021). Efficacy, safety and outcomes
of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: A systematic review and meta-analysis. Diagnostic and
Interventional Imaging, 102(7–8), 479–487. https://doi.org/10.1016/j.diii.2021.03.004
3. Chevallier, O., Fauque, P., Poncelet, C., Guillen, K., Comby, P., Astruc, K., Barberet, J., Falvo, N., Simon, E., & Loffroy, R. (2021). Relevant Biological Effects of Varicocele
Embolization with N-Butyl Cyanoacrylate Glue on Semen Parameters in Infertile Men. Biomedicines, 9(10), 1423. https://doi.org/10.3390/biomedicines9101423
4. Favard, N. et al.Comparison of three different embolic materials for varicocele embolization: retrospective study of tolerance, radiation and recurrence rate. Quant Imaging
Med Surg 5, 806–14 (2015)
5. Comby, P. O. et al.Endovascular Use of Cyanoacrylate-Lipiodol Mixture for Peripheral Embolization: Properties, Techniques, Pitfalls, and Applications. J Clin Med10, (2021).
6. Makris, G.et al. Safety and effectiveness of the different types of embolic materials for the treatment of testicular varicoceles: a systematic review. JBR(2018)
7. DanielY.Sze.et al.Persistent and Recurrent Postsurgical Varicoceles: Venographic Anatomy and Treatment with N-butyl Cyanoacrylate Embolization. J Vasc Interv Radiol
2008; 19:539 –545
8. Study results may differ, and may not cover all VE procedures – these papers are related to PAE, Varicocele and GI Bleeds
9. Study results may differ, and may not cover all VE procedures – these papers are related to Varicocele.
|
|
|
|
P26004632 – July 2026
|
|
